Welcome to our dedicated page for Celanese Del news (Ticker: CE), a resource for investors and traders seeking the latest updates and insights on Celanese Del stock.
Celanese Corporation (symbol: CE) is a global leader in the production and innovation of chemical and specialty materials. Aimed at creating value for its customers, Celanese operates through various segments, including the Acetyl Chain and Materials Solutions. The company is renowned for being one of the largest producers of acetic acid and downstream derivatives, which play critical roles in industries such as chemicals, coatings, and adhesives.
Celanese also excels in the production of specialty polymers, widely utilized in sectors like automotive, electronics, medical, construction, and consumer goods. Additionally, the company produces cellulose derivatives used prominently in cigarette filters, further expanding its diverse product portfolio.
With a global production network and a commitment to innovation, Celanese partners with its clients to bring inspired ideas to life. Recent achievements include expansions in their acetyl chain capabilities and strategic partnerships to enhance their materials solutions offerings.
Financially, Celanese remains robust, continually investing in research and development to foster innovation and maintain a competitive edge. The company's operations are supported by a dedicated team of engineers, scientists, product developers, and problem solvers who strive to meet customer needs while contributing positively to the world.
Latest News:
- Celanese Corporation reports strong quarterly earnings.
- Expansion in the acetyl chain production facilities announced.
- New partnerships established to advance specialty polymer solutions.
Celanese Corporation (NYSE: CE) reported strong second quarter results with GAAP diluted earnings per share of $4.81 and record adjusted earnings per share of $5.02. The company achieved net sales of $2.2 billion, driven by an 18% increase in pricing and a 4% volume rise. Consolidated operating profit reached $567 million, with adjusted EBIT of $691 million. The acquisition of Santoprene™ is anticipated to enhance future earnings. Shareholder returns included $326 million in buybacks and dividends.
Celanese Corporation (NYSE: CE) announced the expansion of its Florence, Kentucky R&D center with a new Pharmaceutical Drug Delivery Feasibility Lab. This expansion aims to enhance development for long-acting controlled release drug delivery, showcasing Celanese's commitment to its Pharmaceutical segment. The lab will provide services such as material characterization and prototyping capabilities, facilitating quicker project advancements for pharmaceutical companies. With over 40 years in the medical market, Celanese aims to innovate drug delivery solutions and improve patient health outcomes.
Celanese Corporation (NYSE:CE) has approved a new $1.0 billion share repurchase authorization, representing approximately 6 percent of the company’s outstanding shares. In the first half of 2021, Celanese utilized $500 million to buy back shares from a previous $1.5 billion authorization. As of June 30, 2021, $560 million remained under that authorization. The addition of this new buyback program supports ongoing shareholder value enhancement.
Celanese Corporation (NYSE: CE) has declared a quarterly cash dividend of $0.68 per share, payable on August 9, 2021. Stockholders of record as of July 26, 2021 will receive the dividend. Celanese is a leading global chemical company with approximately 7,700 employees and reported $5.7 billion in net sales for 2020. The company focuses on differentiated chemistry solutions across various industries and aims to create shareholder value while positively impacting communities through The Celanese Foundation.
Celanese Corporation (NYSE: CE) will host a conference call on July 23, 2021, at 10:00 a.m. Eastern Time to discuss its second quarter 2021 results. The earnings release will be available after market close on July 22. Investors can access the webcast at Celanese Investors. A replay of the call will be accessible from July 23 until August 6, 2021. Celanese is a global leader in specialty materials, employing approximately 7,700 people, with 2020 net sales of $5.7 billion.
Celanese Corporation (NYSE: CE) has signed a definitive agreement to acquire the Santoprene™ TPV elastomers business from Exxon Mobil Corporation for $1.15 billion. This acquisition includes the Santoprene™, Dytron™, and Geolast™ brands, key production facilities, customer contracts, and a comprehensive intellectual property portfolio. Celanese expects the transaction to be accretive to its 2022 adjusted earnings per share and free cash flow. The acquisition aims to enhance Celanese's elastomers portfolio and drive shareholder value, focusing on growth in markets like mobility and sustainability.
Celanese Corporation (NYSE: CE) announced the acquisition of specific polyacetal (POM) production technology from Grupa Azoty S.A., which is discontinuing its POM manufacturing. The deal enables Celanese to serve existing Tarnoform® customers while leveraging its own assets. Although the transaction includes intellectual property and contracts, it does not encompass employees or manufacturing facilities from Azoty. Senior Vice President Tom Kelly highlighted the acquisition as a strategic move to enhance the growth of Celanese's Engineered Materials business. The closing is anticipated for early July 2021.
Celanese Corporation (NYSE: CE) reported first-quarter 2021 GAAP diluted earnings per share of $2.83, adjusted EPS of $3.46, and net sales of $1.8 billion, reflecting a 15% increase in pricing despite a 3% volume decline. Operating profit stood at $326 million, with adjusted EBIT at $482 million, both surpassing pre-COVID levels. The company faced challenges from Winter Storm Uri, incurring costs but maintaining momentum with a strong outlook of adjusted earnings of approximately $4.00 per share for Q2 2021. Celanese returned $328 million to shareholders through buybacks and dividends.
Celanese Corporation (NYSE: CE) announced a quarterly cash dividend of $0.68 per share on its common stock, set to be paid on May 10, 2021. Stockholders recorded as of April 26, 2021 are eligible for this dividend. Celanese is a global leader in chemical and specialty materials production, employing around 7,700 people worldwide and achieving $5.7 billion in net sales for 2020. The company aims to create value through its comprehensive chemistry and technology expertise.
Celanese Corporation (NYSE: CE) has announced a conference call scheduled for April 23, 2021, at 10:00 a.m. Eastern time, to discuss its first quarter 2021 results. The earnings press release will be available after the market closes on April 22, 2021. Interested participants can join via a hosted webcast or dial-in. The call will also be accessible for replay until May 7, 2021. In 2020, Celanese reported net sales of $5.7 billion and employs approximately 7,700 people globally.
FAQ
What is the current stock price of Celanese Del (CE)?
What is the market cap of Celanese Del (CE)?
What does Celanese Corporation do?
What are the primary markets for Celanese's products?
Where is Celanese Corporation based?
What are some recent achievements of Celanese?
How does Celanese contribute to innovation?
What makes Celanese a leader in its industry?
What are cellulose derivatives used for?
What is the significance of Celanese's acetic acid production?
Who are the key personnel at Celanese?
How does Celanese ensure financial stability?
